1. A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation. Issue 4 (9th April 2021) Authors: Zhou, Jie; Curd, Laura; Lohmer, Lauren R. L.; Delpratt, Natalie; Ossig, Joachim; Schippers, Frank; Stoehr, Thomas; Schmith, Virginia D. Journal: Clinical and translational science Issue: Volume 14:Issue 4(2021) Page Start: 1554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. (September 2021) Authors: Stöhr, Thomas; Colin, Pieter J.; Ossig, Joachim; Pesic, Marija; Borkett, Keith; Winkle, Peter; Struys, Michel M.R.F.; Schippers, Frank Journal: British journal of anaesthesia Issue: Volume 127:Number 3(2021) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations. Issue 1 (12th October 2020) Authors: Zhou, Jie; Curd, Laura; Lohmer, Lauren L.; Ossig, Joachim; Schippers, Frank; Stoehr, Thomas; Schmith, Virginia Journal: Clinical and translational science Issue: Volume 14:Issue 1(2021) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗